Talphera
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 15
- Market Cap
- $16.4M
- Introduction
Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.
Talphera's Niyad Receives FDA Agreement for Enrollment Acceleration in NEPHRO CRRT Trial
Talphera has reached an agreement with the FDA for a Prior Approval Supplement (PAS) review to reduce the number of patients in the NEPHRO CRRT study.